Goldman Sachs Group Inc Immunocore Holdings PLC Transaction History

Goldman Sachs Group Inc

$706 Billion
Q2 2025

A detailed history of Goldman Sachs Group Inc transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Goldman Sachs Group Inc holds 44,956 shares of IMCR stock, worth $1.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

44,956

Previous 31,257 43.83%

Holding current value

$1.53 Million

Previous $927,000 52.1%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$24.53 - $38.65 $336,036 - $529,466	13,699 Added 43.83%	44,956 $1.41 Million
Q1 2025 May 09, 2025	SELL	$28.21 - $33.0 $134,900 - $157,806	-4,782 Reduced 13.27%	31,257 $927,000
Q4 2024 Feb 11, 2025	SELL	$28.14 - $34.69 $5.36 Million - $6.6 Million	-190,302 Reduced 84.08%	36,039 $1.06 Million
Q3 2024 Nov 14, 2024	BUY	$30.06 - $41.49 $4.09 Million - $5.65 Million	136,157 Added 150.98%	226,341 $7.05 Million
Q2 2024 Aug 13, 2024	SELL	$33.78 - $63.75 $223,724 - $422,216	-6,623 Reduced 6.84%	90,184 $3.06 Million
Q1 2024 May 15, 2024	BUY	$60.14 - $75.36 $2.89 Million - $3.63 Million	48,135 Added 98.9%	96,807 $6.29 Million
Q4 2023 Feb 13, 2024	SELL	$42.85 - $69.5 $1.14 Million - $1.85 Million	-26,633 Reduced 35.37%	48,672 $3.33 Million
Q3 2023 May 14, 2024	BUY	$49.5 - $66.6 $1.32 Million - $1.77 Million	26,633 Added 54.72%	75,305 $3.91 Million
Q3 2023 Nov 14, 2023	SELL	$49.5 - $66.6 $629,689 - $847,218	-12,721 Reduced 14.45%	75,305 $3.91 Million
Q2 2023 May 14, 2024	BUY	$48.54 - $61.64 $2.28 Million - $2.9 Million	47,046 Added 114.8%	88,026 $5.28 Million
Q2 2023 Aug 14, 2023	BUY	$48.54 - $61.64 $2.28 Million - $2.9 Million	47,046 Added 114.8%	88,026 $5.28 Million
Q1 2023 May 14, 2024	SELL	$46.12 - $65.71 $108,981 - $155,272	-2,363 Reduced 5.45%	40,980 $2.03 Million
Q1 2023 May 11, 2023	SELL	$46.12 - $65.71 $108,981 - $155,272	-2,363 Reduced 5.45%	40,980 $2.03 Million
Q4 2022 May 14, 2024	SELL	$45.51 - $65.08 $242,522 - $346,811	-5,329 Reduced 10.95%	43,343 $2.47 Million
Q4 2022 Feb 13, 2023	BUY	$45.51 - $65.08 $1.97 Million - $2.82 Million	43,343 New	43,343 $2.47 Million

Others Institutions Holding IMCR

# of Institutions

146

Shares Held

45.1M

Call Options Held

297K

Put Options Held

1.17M

View Full List

About Immunocore Holdings plc

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.49B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

More about IMCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Immunocore Holdings PLC Transaction History